Dendritic cells and NK cells

Natural Killer Cells

Volumn , Issue , 2010, Pages 239-253

  Wesa, Amy K ^a   Mailliard, Robbie B ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Celsense Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957484268     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370454-2.00018-1     Document Type: Chapter

References (138)

1. Albert M.L., Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392:86-89.
2. Andrews D.M., Scalzo A.A., Yokoyama W.M., Smyth M.J., Degli-Esposti M.A. Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 2003, 4:175-181.
3. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
4. Bell J.J., Bhandoola A. The earliest thymic progenitors for T cells possess myeloid lineage potential. Nature 2008, 452:764.
5. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.
6. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 1997, 9:24-34.
7. Biron C.A., Byron K.S., Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 1989, 320:1731-1735.
8. Björck P., Kincade P.W. CD19+ pro-B cells can give rise to dendritic cells in vitro. J Immunol 1998, 161:5795-5799.
9. Borg C., Jalil A., Laderach D., Maruyama K., Wakasugi H., Charrier S., Ryffel B., Cambi A., Figdor C., Vainchenker W., Galy A., Caignard A., Zitvogel L. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004, 104:3267-3275.
10. Buza-Vidas N., Luc S., Jacobsen S.E. Delineation of the earliest lineage commitment steps of haematopoietic stem cells: new developments, controversies and major challenges. Curr Opin Hematol 2007, 14:315-321.
11. Campbell J.J., Qin S., Unutmaz D., Soler D., Murphy K.E., Hodge M.R., Wu L., Butcher E.C. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001, 166:6477-6482.
12. Carbone E., Terrazzano G., Ruggiero G., Zanzi D., Ottaiano A., Manzo C., Karre K., Zappacosta S. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol 1999, 29:4022-4029.
13. Carson W.E., Parihar R., Lindemann M.J., Personeni N., Dierksheide J., Meropol N.J., Baselga J., Caligiuri M.A. Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells. Eur J Immunol 2001, 31:3016-3025.
14. Caux C., Vanbervliet B., Massacrier C., Dezutter-Dambuyant C., de Saint-Vis B., Jacquet C., Yoneda K., Imamura S., Schmitt D., Banchereau J. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 1996, 184:695-706.
15. Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000, 1:305-310.
16. Chaix J., Tessmer M.S., Hoebe K., Fuseri N., Ryffel B., Dalod M., Alexopoulou L., Beutler B., Brossay L., Vivier E., Walzer T. Cutting edge: priming of NK cells by IL-18. J Immunol 2008, 181:1627-1631.
17. Chargui J., Oyama A., Yoshimura R., Wada S., Hase T., Kishimoto T. Inhibition of NK cell activity induces improvement and stable chimerism after allogeneic transplantation. Transplant Proc 2000, 32:2462-2463.
18. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
19. Cooper M.A., Fehniger T.A., Ponnappan A., Mehta V., Wewers M.D., Caligiuri M.A. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells. Eur J Immunol 2001, 31:792-801.
20. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
21. Cupedo T., Crellin N.K., Papazian N., Rombouts E.J., Weijer K., Grogan J.L., Fibbe W.E., Cornelissen J.J., Spits H. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009, 10:66-74.
22. Dalod M., Hamilton T., Salomon R., Salazar-Mather T.P., Henry S.C., Hamilton J.D., Biron C.A. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 2003, 197:885-898.
23. Del Vecchio M., Bajetta E., Canova S., Lotze M.T., Wesa A., Parmiani G., Anichini A. Interleukin-12: biological properties and clinical application. Clin Cancer Res 2007, 13:4677-4685.
24. Della Chiesa M., Vitale M., Carlomagno S., Ferlazzo G., Moretta L., Moretta A. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 2003, 33:1657-1666.
25. Dhodapkar K.M., Barbuto S., Matthews P., Kukreja A., Mazumder A., Vesole D., Jagannath S., Dhodapkar M.V. Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma. Blood 2008, 112:2878-2885.
26. Doherty P.C., Allan J.E. Anti-asialo GM1 eliminates both inflammatory process and cytotoxic T-cell function in the lymphocytic choriomeningitis adoptive transfer model. Cell Immunol 1987, 107:1-7.
27. Draghi M., Pashine A., Sanjanwala B., Gendzekhadze K., Cantoni C., Cosman D., Moretta A., Valiante N.M., Parham P. NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 2007, 178:2688-2698.
28. Fanger N.A., Maliszewski C.R., Schooley K., Griffith T.S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med 1999, 190:1155-1164.
29. Fehniger T.A., Cooper M.A., Nuovo G.J., Cella M., Facchetti F., Colonna M., Caligiuri M.A. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003, 101:3052-3057.
30. Ferlazzo G., Semino C., Melioli G. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett 2001, 76:37-41.
31. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002, 195:343-351.
32. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L., Munz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 2004, 101:16606-16611.
33. Ferlazzo G., Thomas D., Lin S.L., Goodman K., Morandi B., Muller W.A., Moretta A., Munz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004, 172:1455-1462.
34. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., Perricaudet M., Tursz T., Maraskovsky E., Zitvogel L. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 1999, 5:405-411.
35. Galea-Lauri J., Darling D., Gan S.U., Krivochtchapov L., Kuiper M., Gaken J., Souberbielle B., Farzaneh F. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. J Immunol 1999, 163:62-70.
36. Gallucci S., Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001, 13:114-119.
37. Galy A., Travis M., Cen D., Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 1995, 3:459-473.
38. Gao J.X., Liu X., Wen J., Caligiuri M.A., Stroynowski I., Zheng P., Liu Y. Two-signal requirement for activation and effector function of natural killer cell response to allogeneic tumor cells. Blood 2003, 102:4456-4463.
39. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002, 195:327-333.
40. Ghiringhelli F., Puig P.E., Roux S., Parcellier A., Schmitt E., Solary E., Kroemer G., Martin F., Chauffert B., Zitvogel L. Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med 2005, 202:919-929.
41. Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., O'Garra A., Liu Y.J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 2002, 195:953-958.
42. Hayakawa Y., Screpanti V., Yagita H., Grandien A., Ljunggren H.G., Smyth M.J., Chambers B.J. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 2004, 172:123-129.
43. Henri S., Vremec D., Kamath A., Waithman J., Williams S., Benoist C., Burnham K., Saeland S., Handman E., Shortman K. The dendritic cell populations of mouse lymph nodes. J Immunol 2001, 167:741-748.
44. Hilkens C.M., Kalinski P., de Boer M., Kapsenberg M.L. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 1997, 90:1920-1926.
45. Hochweller K., Striegler J., Hammerling G.J., Garbi N. A novel CD11c. DTR transgenic mouse for depletion of dendritic cells reveals their requirement for homeostatic proliferation of natural killer cells. Eur J Immunol 2008, 38:2776-2783.
46. Huang J., Tatsumi T., Pizzoferrato E., Vujanovic N., Storkus W.J. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation. Cancer Res 2005, 65:8461-8470.
47. Hughes T., Becknell B., McClory S., Briercheck E., Freud A.G., Zhang X., Mao H., Nuovo G., Yu J., Caligiuri M.A. Stage three immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH17 cytokine interleukin-22. Blood 2009, 113:4008-4010.
48. Hussell T., Openshaw P.J. IL-12-activated NK cells reduce lung eosinophilia to the attachment protein of respiratory syncytial virus but do not enhance the severity of illness in CD8 T cell-immunodeficient conditions. J Immunol 2000, 165:7109-7115.
49. Ito T., Amakawa R., Kaisho T., Hemmi H., Tajima K., Uehira K., Ozaki Y., Tomizawa H., Akira S., Fukuhara S. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002, 195:1507-1512.
50. Iwasaki A., Kelsall B.L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 1999, 190:229-239.
51. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
52. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989, 54(Pt 1):1-13.
53. Jinushi M., Takehara T., Kanto T., Tatsumi T., Groh V., Spies T., Miyagi T., Suzuki T., Sasaki Y., Hayashi N. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 2003, 170:1249-1256.
54. Joncas J., Monczak Y., Ghibu F., Alfieri C., Bonin A., Ahronheim G., Rivard G. Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection. J Med Virol 1989, 28:110-117.
55. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997, 27:3135-3142.
56. Josien R., Wong B.R., Li H.L., Steinman R.M., Choi Y. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells. J Immunol 1999, 162:2562-2568.
57. Kalinski P., Moser M. Consensual immunity: success-driven development of T-helper-1 and T-helper-2 responses. Nat Rev Immunol 2005, 5:251-260.
58. Kalinski P., Hilkens C.M., Wierenga E.A., Kapsenberg M.L. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999, 20:561-567.
59. Kapsenberg M.L. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003, 3:984-993.
60. Karsunky H., Inlay M.A., Serwold T., Bhattacharya D., Weissman I.L. Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood 2008, 111:5562-5570.
61. Katsura Y., Kawamoto H. Stepwise lineage restriction of progenitors in lympho-myelopoiesis. Int Rev Immunol 2001, 20:1-20.
62. Kawakami K. Interleukin-18 and host defense against infectious pathogens. J Immunother 2002, 25(Suppl. 1):S12-S19.
63. Kelly J.M., Darcy P.K., Markby J.L., Godfrey D.I., Takeda K., Yagita H., Smyth M.J. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 2002, 3:83-90.
64. Kikuchi T., Hahn C.L., Tanaka S., Barbour S.E., Schenkein H.A., Tew J.G. Dendritic cells stimulated with Actinobacillus actinomycetemcomitans elicit rapid gamma interferon responses by natural killer cells. Infect Immun 2004, 72:5089-5096.
65. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., Romani N., Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996, 184:741-746.
66. Koka R., Burkett P., Chien M., Chai S., Boone D.L., Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol 2004, 173:3594-3598.
67. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A.M., Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol 2001, 31:3026-3037.
68. Lapointe R., Toso J.F., Butts C., Young H.A., Hwu P. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur J Immunol 2000, 30:3291-3298.
69. Leon B., Ardavin C. Monocyte-derived dendritic cells in innate and adaptive immunity. Immunol Cell Biol 2008, 86:320.
70. Liu Y.J., Kanzler H., Soumelis V., Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2001, 2:585-589.
71. Liu C., Lou Y., Lizee G., Qin H., Liu S., Rabinovich B., Kim G.J., Wang Y.H., Ye Y., Sikora A.G., Overwijk W.W., Liu Y.J., Wang G., Hwu P. Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest 2008, 118:1165-1175.
72. Lotze M.T., Zeh H.J., Rubartelli A., Sparvero L.J., Amoscato A.A., Washburn N.R., Devera M.E., Liang X., Tor M., Billiar T. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 2007, 220:60-81.
73. Mailliard R.B., Egawa S., Cai Q., Kalinska A., Bykovskaya S.N., Lotze M.T., Kapsenberg M.L., Storkus W.J., Kalinski P. Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses. J Exp Med 2002, 195:473-483.
74. Mailliard R.B., Son Y.I., Redlinger R., Coates P.T., Giermasz A., Morel P.A., Storkus W.J., Kalinski P. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 2003, 171:2366-2373.
75. Mailliard R.B., Wankowicz-Kalinska A., Cai Q., Wesa A., Hilkens C.M., Kapsenberg M.L., Kirkwood J.M., Storkus W.J., Kalinski P. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 2004, 64:5934-5937.
76. Mailliard R.B., Alber S.M., Shen H., Watkins S.C., Kirkwood J.M., Herberman R.B., Kalinski P. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 2005, 202:941-953.
77. Maldonado-Lopez R., De Smedt T., Pajak B., Heirman C., Thielemans K., Leo O., Urbain J., Maliszewski C.R., Moser M. Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol 1999, 66:242-246.
78. Maldonado-Lopez R., Maliszewski C., Urbain J., Moser M. Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol 2001, 167:4345-4350.
79. Manz M.G., Traver D., Miyamoto T., Weissman I.L., Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 2001, 97:3333-3341.
80. Marquez C., Trigueros C., Franco J.M., Ramiro A.R., Carrasco Y.R., Lopez-Botet M., Toribio M.L. Identification of a common developmental pathway for thymic natural killer cells and dendritic cells. Blood 1998, 91:2760-2771.
81. Martin-Fontecha A., Assarsson E., Carbone E., Karre K., Ljunggren H.G. Triggering of murine NK cells by CD40 and CD86 (B7-2). J Immunol 1999, 162:5910-5916.
82. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004, 5:1260-1265.
83. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002, 2:957-964.
84. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001, 19:197-223.
85. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996, 17:138-146.
86. Murphy W.J., Koh C.Y., Raziuddin A., Bennett M., Longo D.L. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev 2001, 181:279-289.
87. Naik S.H., Sathe P., Park H.Y., Metcalf D., Proietto A.I., Dakic A., Carotta S., O'Keeffe M., Bahlo M., Papenfuss A., Kwak J.Y., Wu L., Shortman K. Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 2007, 8:1217-1226.
88. O'Connell P.J., Son Y.I., Giermasz A., Wang Z., Logar A.J., Thomson A.W., Kalinski P. Type-1 polarized nature of mouse liver CD8alpha- and CD8alpha+dendritic cells: tissue-dependent differences offset CD8alpha-related dendritic cell heterogeneity. Eur J Immunol 2003, 33:2007-2013.
89. Onai N., Obata-Onai A., Schmid M.A., Ohteki T., Jarrossay D., Manz M.G. Identification of clonogenic common Flt3+ M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 2007, 8:1207-1216.
90. Parihar R., Dierksheide J., Hu Y., Carson W.E. IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells. J Clin Invest 2002, 110:983-992.
91. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002, 195:335-341.
92. Poggi A., Massaro A.M., Negrini S., Contini P., Zocchi M.R. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors. J Immunol 2005, 174:2653-2660.
93. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 1999, 96:1036-1041.
94. Rathinam C., Flavell R.A. The hematopoiesis paradigm: clarity or ambiguity?. Blood 2008, 112:3534-3535.
95. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186.
96. Ruggeri L., Capanni M., Urbani E., Perruccio K., Shlomchik W.D., Tosti A., Posati S., Rogaia D., Frassoni F., Aversa F., Martelli M.F., Velardi A. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002, 295:2097-2100.
97. Sanchez M.J., Muench M.O., Roncarolo M.G., Lanier L.L., Phillips J.H. Identification of a common T/natural killer cell progenitor in human fetal thymus. J Exp Med 1994, 180:569-576.
98. Scharton T.M., Scott P. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med 1993, 178:567-577.
99. Schmitz M., Zhao S., Schakel K., Bornhauser M., Ockert D., Rieber E.P. Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity. Blood 2002, 100:1502-1504.
100. Schmitz M., Zhao S., Deuse Y., Schakel K., Wehner R., Wohner H., Holig K., Wienforth F., Kiessling A., Bornhauser M., Temme A., Rieger M.A., Weigle B., Bachmann M., Rieber E.P. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J Immunol 2005, 174:4127-4134.
101. Schoenberger S.P., Toes R.E., van der Voort E.I., Offringa R., Melief C.J. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393:480-483.
102. Semino C., Angelini G., Poggi A., Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 2005, 106:609-616.
103. Semino C., Ceccarelli J., Lotti L.V., Torrisi M.R., Angelini G., Rubartelli A. The maturation potential of NK cell clones toward autologous dendritic cells correlates with HMGB1 secretion. J Leukoc Biol 2007, 81:92-99.
104. Shah J.A., Darrah P.A., Ambrozak D.R., Turon T.N., Mendez S., Kirman J., Wu C.-Y., Glaichenhaus N., Seder R.A. Dendritic cells are responsible for the capacity of CpG oligodeoxynucleotides to act as an adjuvant for protective vaccine immunity against Leishmania major in mice. J Exp Med 2003, 198:281-291.
105. Shigematsu H., Reizis B., Iwasaki H., Mizuno S., Hu D., Traver D., Leder P., Sakaguchi N., Akashi K. Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 2004, 21:43-53.
106. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007, 7:19-30.
107. Shreedhar V., Moodycliffe A.M., Ullrich S.E., Bucana C., Kripke M.L., Flores-Romo L. Dendritic cells require T cells for functional maturation in vivo. Immunity 1999, 11:625-636.
108. Snijders A., Kalinski P., Hilkens C.M., Kapsenberg M.L. High-level IL-12 production by human dendritic cells requires two signals. Int Immunol 1998, 10:1593-1598.
109. Son Y.I., Dallal R.M., Mailliard R.B., Egawa S., Jonak Z.L., Lotze M.T. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Cancer Res 2001, 61:884-888.
110. Stary G., Bangert C., Tauber M., Strohal R., Kopp T., Stingl G. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. J Exp Med 2007, 204:1441-1451.
111. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991, 9:271-296.
112. Stumbles P.A., Thomas J.A., Pimm C.L., Lee P.T., Venaille T.J., Proksch S., Holt P.G. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998, 188:2019-2031.
113. Summers K.L., Hock B.D., McKenzie J.L., Hart D.N.J. Phenotypic characterization of five dendritic cell subsets in human tonsils. Am J Pathol 2001, 159:285-295.
114. Szomolanyi-Tsuda E., Brien J.D., Dorgan J.E., Garcea R.L., Woodland R.T., Welsh R.M. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology 2001, 280:160-168.
115. Tiberghien P., Longo D.L., Wine J.W., Alvord W.G., Reynolds C.W. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood 1990, 76:1419-1430.
116. Tominaga K., Yoshimoto T., Torigoe K., Kurimoto M., Matsui K., Hada T., Okamura H., Nakanishi K. IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells. Int Immunol 2000, 12:151-160.
117. Traver D., Akashi K., Manz M., Merad M., Miyamoto T., Engleman E.G., Weissman I.L. Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science 2000, 290:2152-2154.
118. Trinchieri G. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 1998, 70:83-243.
119. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146.
120. Trinite B., Chauvin C., Peche H., Voisine C., Heslan M., Josien R. Immature CD4-CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims. J Immunol 2005, 175:2408-2417.
121. Uhl M., Kepp O., Jusforgues-Saklani H., Vicencio J.M., Kroemer G., Albert M.L. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8(+) T cells. Cell Death Differ 2009, 16:991-1005.
122. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., Martin B., Wilhelm C., Stockinger B. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008, 9:1341-1346.
123. Vieira P.L., de Jong E.C., Wierenga E.A., Kapsenberg M.L., Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 2000, 164:4507-4512.
124. Visintin A., Mazzoni A., Spitzer J.H., Wyllie D.H., Dower S.K., Segal D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001, 166:249-255.
125. Vitale M., Della Chiesa M., Carlomagno S., Pende D., Arico M., Moretta L., Moretta A. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005, 106:566-571.
126. Wada H., Masuda K., Satoh R., Kakugawa K., Ikawa T., Katsura Y., Kawamoto H. Adult T-cell progenitors retain myeloid potential. Nature 2008, 452:768-772.
127. Watt S.V., Andrews D.M., Takeda K., Smyth M.J., Hayakawa Y. IFN-gamma-dependent recruitment of mature CD27(high) NK cells to lymph nodes primed by dendritic cells. J Immunol 2008, 181:5323-5330.
128. Welner R.S., Pelayo R., Nagai Y., Garrett K.P., Wuest T.R., Carr D.J., Borghesi L.A., Farrar M.A., Kincade P.W. Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection. Blood 2008, 112:3753-3761.
129. Wesa A.K., Galy A. Regulation of T cell cytokine production by dendritic cells generated in vitro from hematopoietic progenitor cells. Cell Immunol 2001, 208:115-124.
130. Wesa A., Galy A. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC Immunol 2002, 3:14.
131. Wesa A.K., Storkus W.J. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer. Cell Death Differ 2008, 15:51-57.
132. Wesa A., Kalinski P., Kirkwood J.M., Tatsumi T., Storkus W.J. Polarized type-1 dendritic cells (DC1) producing high levels of IL-12 family members rescue patient TH1-type antimelanoma CD4+ T cell responses in vitro. J Immunother 2007, 30:75-82.
133. Wilson J.L., Charo J., Martin-Fontecha A., Dellabona P., Casorati G., Chambers B.J., Kiessling R., Bejarano M.T., Ljunggren H.G. NK cell triggering by the human costimulatory molecules CD80 and CD86. J Immunol 1999, 163:4207-4212.
134. Wu L., Li C.L., Shortman K. Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med 1996, 184:903-911.
135. Wu L., Vandenabeele S., Georgopoulos K. Derivation of dendritic cells from myeloid and lymphoid precursors. Int Rev Immunol 2001, 20:117-135.
136. Xu Y., Zhan Y., Lew A.M., Naik S.H., Kershaw M.H. Differential development of murine dendritic cells by GM-CSF versus Flt3 ligand has implications for inflammation and trafficking. J Immunol 2007, 179:7577-7584.
137. Yu Y., Hagihara M., Ando K., Gansuvd B., Matsuzawa H., Tsuchiya T., Ueda Y., Inoue H., Hotta T., Kato S. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol 2001, 166:1590-1600.
138. Zhang A.L., Colmenero P., Purath U., Teixeira de Matos C., Hueber W., Klareskog L., Tarner I.H., Engleman E.G., Soderstrom K. Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 2007, 110:2484-2493.